Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs (2022)
- Authors:
- USP affiliated authors: LOPES, LUCIANA BIAGINI - ICB ; LOTUFO, LETICIA VERAS COSTA - ICB ; MIGUEL, RODRIGO DOS ANJOS - ICB ; HIRATA, AMANDA SOARES - ICB
- Unidade: ICB
- DOI: 10.3390/pharmaceutics14081722
- Subjects: FARMACOLOGIA; QUIMIOTERÁPICOS; PRODUTOS NATURAIS; NANOTECNOLOGIA; ANTIBIÓTICOS; ANTINEOPLÁSICOS; FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutics
- ISSN: 1999-4923
- Volume/Número/Paginação/Ano: v. 14, n. 8, art. 1722, p. 1-28, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MIGUEL, Rodrigo dos Anjos et al. Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs. Pharmaceutics, v. 14, n. 8, p. 1-28, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14081722. Acesso em: 27 dez. 2025. -
APA
Miguel, R. dos A., Hirata, A. S., Jimenez, P. C., Lopes, L. B., & Costa-Lotufo, L. V. (2022). Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs. Pharmaceutics, 14( 8), 1-28. doi:10.3390/pharmaceutics14081722 -
NLM
Miguel R dos A, Hirata AS, Jimenez PC, Lopes LB, Costa-Lotufo LV. Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs [Internet]. Pharmaceutics. 2022 ; 14( 8): 1-28.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3390/pharmaceutics14081722 -
Vancouver
Miguel R dos A, Hirata AS, Jimenez PC, Lopes LB, Costa-Lotufo LV. Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs [Internet]. Pharmaceutics. 2022 ; 14( 8): 1-28.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3390/pharmaceutics14081722 - Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline
- Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma
- Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase
- Caracterização do mecanismo de ação da seriniquinona e derivados sintéticos em modelos celulares de melanoma
- Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models
- Multifunctional nanoemulsions promote cutaneous co-localization of chemotherapeutic agents and improve efficacy in 3D models of skin cancer
- Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment
- Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment
- Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas
- Bismuth(III) triflate: an economical and environmentally friendly catalyst for the Nazarov reaction
Informações sobre o DOI: 10.3390/pharmaceutics14081722 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Beyond Formulation. Contr... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
